Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novacare (NOV) breaking out... -- Ignore unavailable to you. Want to Upgrade?

To: Andrew who wrote (345)	12/2/1998 6:21:00 PM
From: simarx	Read Replies (1) \| Respond to of 420

What hurt the stock are two fold: 1) Medicare changes which affects their revenue. 2) Management problems. The company had already taken measures to mitigate the medicare effect, but it was not enough. However, the two reasons above are what account for the current price. Basically the negative effect has already taken place. The question is, does the current price fairly value the stock. I believe it doesn't. Does that mean that it will not go any lower? It just may, however, at this price, it is probably wise to start a position, and begin averaging as we can't be sure when it will correct upwardly. What we do know is that the company is followed by a few influential firms. I'm hoping for a post January 1 correction. It's cheap enough to take a risk on...